Ether Anaesthesia and the Boston Demonstrations, 1846

This entry concerns ether's public introduction into Euro-American hospital surgery. It should not be mistaken for a universal origin story. On 13 October 1804, Hanaoka Seishū performed breast-cancer surgery in Kii Province, Japan, using the orally administered herbal anaesthetic mafutsusan (also called tsūsensan). The formula drew on a Chinese anaesthetic tradition but was developed and used within Japan (Japanese Society of Anesthesiologists).

In the United States, ether was already familiar as a solvent, medicine and intoxicant at “ether frolics.” Crawford W. Long later reported that on 30 March 1842 in Jefferson, Georgia, he used it while removing a neck tumour from James Venable and used it in further operations. His account appeared only in December 1849, after the Boston success and during a priority contest; it is evidence of earlier practice but not of the route by which the 1846 method spread (Long; Firth).

Horace Wells's nitrous-oxide dental work in Hartford in 1844–45 supplied Morton's most immediate precedent. Its poorly received Boston demonstration also showed why a drug effect, convincing administration, credible witnesses and prompt communication could not be separated. Morton had been Wells's partner; his later effort to claim ether as an exclusive discovery flattened this shared history (Frampton).

1. 30 March 1842: according to Long's 1849 publication and supporting certificates gathered after the event, he administers ether to James Venable for removal of a neck tumour in Jefferson, Georgia. The delay in publication limits what the report can establish about contemporary circulation (Long).
2. December 1844–January 1845: Wells uses nitrous oxide for dental extractions in Hartford and attempts a Boston demonstration. The disputed and poorly documented result does not produce durable adoption; see the separate dental anaesthesia entry.
3. 30 September 1846: Morton gives ether to Eben Frost for a molar extraction in his Boston office. A witness and a report in the Boston Daily Journal make this private dental case part of the public trail (Firth).
4. 16 October: at Massachusetts General Hospital, Morton administers ether to Abbott while Warren attempts to ligate the blood supply of a congenital lesion under the jaw. Abbott is not fully unconscious; the evidential meaning of the case is contested (Bigelow; Firth).
5. 17 October: George Hayward removes a fatty tumour from a woman's upper arm. Bigelow reports that she showed some uneasiness but afterwards said she had felt no pain and knew nothing of the operation (Bigelow).
6. 7 November: Hayward performs an above-knee amputation on a young woman under ether; Warren then operates on another patient's jaw. The amputation offered more persuasive evidence during a severe operation, although the patient cried out when the sciatic nerve was divided (Bigelow; Firth).
7. 18 November: Bigelow publishes “Insensibility during Surgical Operations Produced by Inhalation” in the Boston Medical and Surgical Journal. His report presents successful cases alongside partial effects, failures, vomiting and a dangerous episode of depressed pulse and respiration (Bigelow).
8. 19–21 December: after news arrives from Boston, James Robinson administers ether for a dental extraction at Francis Boott's London home on 19 December. On 21 December, Robert Liston amputates a thigh at University College Hospital with ether administered by William Squire. Print, letters, ships, instruments and professional networks carried practice across the Atlantic (Royal College of Anaesthetists).
9. 1847: practitioners adapt inhalers and learn administration by experience. John Snow publishes an early practical book on ether, while chloroform begins to displace ether in Britain despite its own serious dangers (Royal College of Anaesthetists).

Abbott was 21 and had a congenital, compressible mass extending beneath the left jaw and into the mouth. The hospital called it an “erectile tumor,” a nineteenth-century term for a vascular lesion, not a diagnosis of cancer or sexual disease. Warren exposed a tangle of vessels and placed a ligature around the mass; he did not excise it. Abbott's wound healed, but the mass was still about the same size when he left hospital on 7 December (Firth).

The anaesthetic result is also less tidy than later commemoration. In his paper written within weeks, Bigelow said Abbott muttered and afterwards described “considerable” but reduced pain. A retrospective addendum pasted into the hospital record says that he did not respond to the first incision, later moved and cried out, knew the operation was happening, but denied pain afterwards. Firth concludes that the general anaesthesia was incomplete and that this single case was inconclusive; the following operations strengthened the claim (Bigelow; Firth).

Warren's reputed verdict, “Gentlemen, this is no humbug,” is not in the contemporary accounts. Firth traces it to Nathan P. Rice's 1859 biography of Morton, published thirteen years later to advance Morton's claim to sole credit and after Warren's death. It is a durable institutional legend, not secure eyewitness evidence (Firth).

Abbott's own experience reaches readers through clinicians' notes and later reconstructions. Those sources record his reported sensation, but not a modern consent process, systematic follow-up in his own voice, or a standardized measure of awareness and pain. His participation made the public proof possible while the archive left him far less agency than the men disputing ownership of the method (Firth).

“Sulphuric ether” was the period name for the substance now generally called diethyl or ethyl ether; it did not mean that patients inhaled sulphuric acid (Bigelow; NIOSH). Morton's apparatus was a small two-necked glass globe with ether-soaked sponges, an air inlet, a tube and a mouthpiece valve. The patient's breath drew vapour from the globe, but coughing, mouth opening, leakage, excitement and the duration of inhalation all changed the result (Bigelow).

Bigelow observed induction times ranging from roughly two to eight minutes and only a few minutes of insensibility after the apparatus was removed. His series included partial consciousness, resistance, nausea and vomiting in children, failure to produce an effect, and one prolonged administration followed by dangerously weak pulse, slow breathing and cold hands. His article was advocacy for a promising method, but it did not hide all of its instability (Bigelow).

Early practitioners had no standardized concentration, dedicated anaesthesia record or routine vital-sign chart. Diethyl ether is also highly flammable, a material danger that later constrained its use around ignition sources. These facts distinguish the 1846 experiment from modern general anaesthesia and explain why apparatus design, monitoring and a skilled administrator became central rather than incidental (Andrew, Gitlin, and Desai; NIOSH).

Morton initially concealed the agent's identity under the name “Letheon.” He had sought advice from the chemist Charles T. Jackson, whose precise contribution became bitterly disputed, and the two were named in an American patent arrangement. Once practitioners recognized that Letheon was ether, the attempted monopoly appeared both difficult to enforce and, to many medical writers, incompatible with professional obligations to relieve suffering (Frampton).

Priority depends on the act being credited. Hanaoka developed a different general anaesthetic tradition in Japan; Long documented earlier ether operations only later; Wells established an important dental use for nitrous oxide; Jackson advised Morton; Morton organized the dental and hospital trials; Warren granted institutional access; Hayward performed the clearest early Boston operations; Bigelow converted cases into a publishable method; and patients supplied the bodily evidence. No single “discoverer of anaesthesia” adequately describes those contributions (Firth; Frampton).

Boston nevertheless mattered because its network could circulate the result. Bigelow presented the work to learned societies, published it in a medical journal, and described enough of the apparatus and effects for others to experiment. Letters and print crossed the Atlantic in December; local dentists, physicians, surgeons and instrument makers then rebuilt the method in British practice (Bigelow; Royal College of Anaesthetists).

A modern study of forty Massachusetts General Hospital surgical records from February 1846 to March 1847 found that recorded operations rose from about 1.6 to 5.6 per month across the periods studied. Seventeen of the twenty-eight post-demonstration operations used general anaesthesia, while eleven still did not. The numbers are small, come from one hospital, and cannot establish a universal rate of adoption, but they show both rapid local uptake and continued selectivity (Andrew, Gitlin, and Desai).

The same records contain wound infection, partial anaesthesia, struggling, asphyxial symptoms and operations with no vital signs recorded. Anaesthesia did not cause antisepsis, asepsis, blood transfusion or reliable control of shock. Those separate developments shaped which deeper and longer procedures could be survived; see antiseptic surgery for the later struggle against operative infection (Andrew, Gitlin, and Desai).

The documented change was nonetheless profound: operative pain was no longer necessarily the price of remaining conscious, and surgeons could increasingly make precision rather than speed their immediate priority. That altered the moral negotiation between practitioner and patient as well as surgical technique. It took repeated administration, specialist knowledge, safer equipment and institutional routines—not Ether Day alone—to turn that possibility into dependable practice (Royal College of Anaesthetists).